Academic Journal

Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD

التفاصيل البيبلوغرافية
العنوان: Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
المؤلفون: Barb, Diana, Kalavalapalli, Srilaxmi, Leiva, Eddison Godinez, Bril, Fernando, Huot-Marchand, Philippe, Dzen, Lucile, Rosenberg, Jens T., Junien, Jean-Louis, Broqua, Pierre, Rocha, Andrea Ortiz, Lomonaco, Romina, Abitbol, Jean-Louis, Cooreman, Michael P., Cusi, Kenneth
المساهمون: University of Florida, Inventiva SA
المصدر: Journal of Hepatology ; ISSN 0168-8278
بيانات النشر: Elsevier BV
سنة النشر: 2025
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jhep.2024.12.045
الاتاحة: https://doi.org/10.1016/j.jhep.2024.12.045
https://api.elsevier.com/content/article/PII:S0168827825000029?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0168827825000029?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.7275CCB
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.jhep.2024.12.045